K2M Strengthens Biologics Portfolio With Launch of VENADO Bone Graft Systems  
3/27/2013 11:19:21 AM

LEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company’s U.S. biologics offering with the launch of the VENADO® Foam Strips and VENADO Granules Bone Graft Systems. VENADO represents an entirely new product family in K2M’s growing biologics portfolio, already featuring VIKOS® Allograft Systems and VESUVIUSTM Osteobiologic Systems. The systems are available in a variety of configurations and sizes specifically designed to enhance bone regeneration and act as an osteogenic stimulus after spine surgery. VENADO Foam Strips are purified fibrillar collagen and biphasic granules. The Foam Strips hydrate quickly in blood or saline, and become very flexible and moldable, yet are less likely to dissociate or break apart. When bone cells migrate into the graft composite, the implant functions as a scaffold for osteogenic components. VENADO Granules are a biphasic combination of hydroxyapatite and beta-tricalcium phosphate with excellent resorption characteristics.